Related Experiment Video
Updated: Jul 13, 2026
04:56
Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
TFDP3 inhibits E2F1-induced, p53-mediated apoptosis
1Department of Immunology, Peking University Health Science Center, 38 Xue Yuan Road, Beijing 100083, China.
Biochemical and Biophysical Research Communications
|July 17, 2007
Summary
Transcription factor DP family member 3 (TFDP3) inhibits E2F1-induced apoptosis. TFDP3 suppresses p53 accumulation and pro-apoptotic gene expression, revealing a novel regulatory mechanism for E2F1 activity.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Transcription factor dimerization partner (TFDP) proteins modulate E2F transcription factor activity.
- TFDP1 and TFDP2 enhance E2F activity, while TFDP3 acts as a negative regulator.
- The specific inhibitory mechanisms of TFDP3 require further elucidation.
Purpose of the Study:
- To investigate the role of TFDP3 in regulating E2F1-induced apoptosis.
- To characterize the molecular mechanisms underlying TFDP3's inhibitory function.
Main Methods:
- Ectopic expression of E2F1 and TFDP3 in HEK-293 cells.
- Assessment of apoptosis induction via E2F1.
- Analysis of p53 protein levels and pro-apoptotic gene expression (Bax, Puma, Noxa, Bid).
Main Results:
- Ectopic E2F1 expression induced apoptosis in HEK-293 cells.
- Co-transfection with TFDP3 significantly abolished E2F1-induced apoptosis.
- TFDP3 suppressed E2F1-mediated accumulation of p53 and expression of pro-apoptotic genes.
Conclusions:
- TFDP3 functions as a novel inhibitor of E2F1-induced apoptosis.
- TFDP3 regulates apoptosis by suppressing p53 accumulation and pro-apoptotic gene expression.
- These findings highlight TFDP3's critical role in controlling E2F-mediated cellular processes.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...